Integra LifeSciences Holdings Corporation Earning Date (IART)

USA |NASDAQ |USD

IART Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 26, 2022 Jun 2022 $0.80 - $0.79
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 26, 2022 Jun 2022 $394.32M - $389.99M

Integra Lifesciences Holdings Corporation's next earnings date is Tuesday, Jul 26, 2022 for the fiscal quarter ending Jun 2022.

IART Earnings Date & History Chart

IART Earnings & Revenue Forecast

IART Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 12 $0.80 $0.78 $0.83
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 13 $3.31 $3.28 $3.35
Dec 2023 14 $3.67 $3.54 $3.99

IART Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 0 $0.80 $0.83 $0.84
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $3.31 $3.42 $3.42
Dec 2023 0 / 0 $3.67 $3.81 $3.81

IART Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 11 $394.32M $385.46M $403.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 13 $1.59B $1.58B $1.60B
Dec 2023 13 $1.68B $1.67B $1.70B

IART Earnings Date & Revenue History

IART Earnings History

|
Show More
Show More

IART Revenue History

|
Show More
Show More

Integra Lifesciences Holdings Corporation Next Earnings Date & Report

IART Next Earnings Date & Report Preview: Jun 2022 (FQ)

IART's next earnings date is Tuesday, Jul 26, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Integra Lifesciences Holdings Corporation's next quarterly earnings is $0.80, with a low EPS estimation of $0.78, and a high estimation of $0.83.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.80, the last 2 month trend is $0.83, and the 3 month trend is $0.84.

Based on analysts, the average revenue estimation is $394.32M, with a low revenue estimation of $385.46M, and a high estimation of $403.80M.

Integra Lifesciences Holdings Corporation Previous Earnings Dates & Reports

IART Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Integra Lifesciences Holdings Corporation's previous earnings date was Apr 27, 2022 for its fiscal quarter ended Mar 31, 2022.

IART Previous Earnings Date & Report Recap: Dec 2021 (FY)

Integra Lifesciences Holdings Corporation's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.

IART's earnings per share (EPS) was $3.18, beating the consensus analysts forecast of $3.16 by 0.63% , and higher than the previous year's EPS (Dec 2020) by 29.80%.

Revenues were $1.54B, better than the forecast of $1.54B by 0.14%, and up by 12.43% from previous year's revenue.

The company reported a net income of $169.07M, 26.28% higher than the previous year.

Integra Lifesciences Holdings Corporation reported a free cash flow of $312.43M for its fiscal year, compared to $139.94M a year ago.

The company ended the fiscal year with $944.14M in total debt, a decrease of -42.97% compared to the previous year.